Ftse Mib
34.301,58
-1,06%
DAX
18.417,54
-1,04%
S&P 500
5.264,38
-0,36%
NASDAQ
16.767,05
-0,37%
Bitcoin
70.173,33
1,99%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Jazz Pharmaceuticals PLC (JAZZ) Jazz Pharmaceuticals PLC (JAZZ) Notizie

Jazz Pharmaceuticals PLC

JAZZ
104,52
-1,22 (-1,15%)
Ultimo aggiornamento: 17:31:45
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/6/202422:28EDGAR2Form PRE 14A - Other preliminary proxy statements
01/6/202414:05PRNUSJazz Pharmaceuticals Presents Overall Survival and Longer..
31/5/202423:01EDGAR2Form 8-K - Current report
30/5/202413:30PRNUSJazz Pharmaceuticals Showcases Pioneering Research in Sleep..
29/5/202422:15PRNUSJazz Pharmaceuticals to Participate in Upcoming June..
29/5/202413:45PRNUSZanidatamab Granted Priority Review for HER2-Positive..
22/5/202414:00PRNUSJazz Pharmaceuticals Announces Collaboration with Life..
07/5/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/5/202422:10PRNUSJazz Pharmaceuticals to Participate in the BofA Securities..
01/5/202422:05PRNUSJazz Pharmaceuticals Announces First Quarter 2024 Financial..
24/4/202422:05PRNUSJazz Pharmaceuticals to Present Data Across Growing Oncology..
17/4/202422:15PRNUSJazz Pharmaceuticals to Report 2024 First Quarter Financial..
10/4/202413:45PRNUSJazz Pharmaceuticals to Showcase Expansive Neuroscience..
02/4/202413:30PRNUSJazz Pharmaceuticals Completes Zanidatamab Biologics License..
12/3/202421:15PRNUSJazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on..
09/3/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:09EDGAR2Form 144 - Report of proposed sale of securities
06/3/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/3/202421:11EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:06EDGAR2Form 8-K - Current report
28/2/202422:05PRNUSJazz Pharmaceuticals Announces Full Year and Fourth Quarter..
27/2/202413:45EDGAR2Form 8-K - Current report
27/2/202413:45PRNUSJazz Pharmaceuticals Appoints Patrick Kennedy to its Board..
21/2/202413:46EDGAR2Form 8-K - Current report
21/2/202413:45PRNUSJazz Pharmaceuticals Appoints Philip Johnson as Chief..
20/2/202422:15PRNUSJazz Pharmaceuticals to Participate in Upcoming March..
14/2/202422:15PRNUSJazz Pharmaceuticals to Report 2023 Full Year and Fourth..
07/2/202408:00PRNUSJazz Pharmaceuticals Enters Definitive Agreement with Redx..
25/1/202423:01EDGAR2Form 8-K - Current report
24/1/202415:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/1/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202413:45EDGAR2Form 8-K - Current report
21/12/202322:05PRNUSJazz Pharmaceuticals Provides Update on Phase 2 Trial of..
20/12/202322:15PRNUSJazz Pharmaceuticals to Present at the 42nd Annual J.P...
Apertura: 105,48 Min: 104,45 Max: 106,20
Chiusura: 105,74

La tua Cronologia

NASDAQ
JAZZ
Jazz Pharmaceuticals
COIN
BIDZUST
Bidz Coin
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network